UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Relationship Between Patient Characteristics and Number of Procedures as well as Length of Stay for Patients Surviving Severe Burn Injuries: Analysis of the American Burn Association National Burn Repository

Journal of burn care & research, 2020-09, Vol.41 (5), p.1037-1044

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of intensification with SGLT2 inhibitors for type 2 diabetes

The American journal of managed care, 2021-08, Vol.27 (8), p.e269-e277

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product

PloS one, 2019-11, Vol.14 (11), p.e0224700

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of DPP-4 inhibitor and SGLT2 inhibitor combination therapy for type 2 diabetes

The American journal of managed care, 2019-05, Vol.25 (5), p.231-238

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost‐effectiveness of intensification with sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes on metformin and sitagliptin vs direct intensification with insulin in the United Kingdom

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.1010-1017

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy

The New England journal of medicine, 2005-02, Vol.352 (6), p.570-585

2005

Link zum Volltext

Verfügbarkeit prüfen

Economic burden of toxicities associated with treating metastatic melanoma in eight countries

The European journal of health economics, 2017-01, Vol.18 (1), p.49-58

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States

Frontiers in immunology, 2024-05, Vol.15, p.1393939-1393939

2024

Link zum Volltext

Verfügbarkeit prüfen

936-P: Annual Cost to Achieve Cost Effectiveness of Continuous Glucose Monitoring in Hypoglycemia-Unaware Type 1 Diabetes Patients Using Intensive Insulin in the United Kingdom

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

1275-P: Cost Effectiveness of Using DPP-4i and SGLT2i Combination Therapy vs. Switching to GLP-1 Therapy for the Management of Type 2 Diabetes

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension

Journal of medical economics, 2023, Vol.26 (1), p.1349-1355

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States

Current medical research and opinion, 2020-01, Vol.36 (1), p.23-32

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Analysis of Flash Glucose Monitoring System for People with Type 2 Diabetes Receiving Intensive Insulin Treatment

Diabetes therapy, 2022-12, Vol.13 (11-12), p.1933-1945

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United States

Value in health, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

US cost-effectiveness and budget impact of point-of-care NAAT for streptococcus

The American journal of managed care, 2021-05, Vol.27 (5), p.e157-e163

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden

European Endocrinology, 2018-09, Vol.14 (2), p.73-79

2018

Link zum Volltext

Verfügbarkeit prüfen

The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden

European Endocrinology, 2018-09, Vol.14 (2), p.80-85

2018

Link zum Volltext

Verfügbarkeit prüfen

Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States

American health & drug benefits, 2016-06, Vol.9 (4), p.203-213

2016

Link zum Volltext

Verfügbarkeit prüfen

The Prevalence, Correlates, and Impact of Logically Inconsistent Preferences in Utility Assessments for Joint Health States in Prostate Cancer

Medical care, 2011-01, Vol.49 (1), p.59-66

2011

Link zum Volltext

Verfügbarkeit prüfen

The Association Between Noncancer Pain, Cognitive Impairment, and Functional Disability: An Analysis of the Canadian Study of Health and Aging

The journals of gerontology. Series A, Biological sciences and medical sciences, 2010-08, Vol.65A (8), p.880-886

2010

Link zum Volltext

Verfügbarkeit prüfen

Functional outcomes in head and neck cancer

Seminars in radiation oncology, 2004-04, Vol.14 (2), p.178-189

2004

Link zum Volltext

Verfügbarkeit prüfen

Evaluations of quality of life and organ function

Seminars in oncology, 2004-12, Vol.31 (6), p.827-835

2004

Link zum Volltext

Verfügbarkeit prüfen

RETRACTED ARTICLE: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension

Journal of medical economics, 2023-12, Vol.26 (1), p.1349-1355

2023

Link zum Volltext

Verfügbarkeit prüfen

Modeling Long-Term Cost-Effectiveness of Sitagliptin and SGLT2i Combination Therapy for the Treatment of Type 2 Diabetes

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost Effectiveness of DPP-4i and SGLT2i Combination Therapy for the Treatment of Type 2 Diabetes in the U.S

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(59)
Buchkapitel
(1)

Sprache

Englisch
(59)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Relationship Between Patient Characteristics and Number of Procedures as well as Length of Stay for Patients Surviving Severe Burn Injuries: Analysis of the American Burn Association National Burn Repository

Cost-effectiveness of intensification with SGLT2 inhibitors for type 2 diabetes

Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product

Cost-effectiveness of DPP-4 inhibitor and SGLT2 inhibitor combination therapy for type 2 diabetes

Cost‐effectiveness of intensification with sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes on metformin and sitagliptin vs direct intensification with insulin in the United Kingdom

Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy

Economic burden of toxicities associated with treating metastatic melanoma in eight countries

Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States

936-P: Annual Cost to Achieve Cost Effectiveness of Continuous Glucose Monitoring in Hypoglycemia-Unaware Type 1 Diabetes Patients Using Intensive Insulin in the United Kingdom

1275-P: Cost Effectiveness of Using DPP-4i and SGLT2i Combination Therapy vs. Switching to GLP-1 Therapy for the Management of Type 2 Diabetes

Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension

Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States

Cost-Effectiveness Analysis of Flash Glucose Monitoring System for People with Type 2 Diabetes Receiving Intensive Insulin Treatment

Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United States

US cost-effectiveness and budget impact of point-of-care NAAT for streptococcus

Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden

The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden

Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States

The Prevalence, Correlates, and Impact of Logically Inconsistent Preferences in Utility Assessments for Joint Health States in Prostate Cancer

The Association Between Noncancer Pain, Cognitive Impairment, and Functional Disability: An Analysis of the Canadian Study of Health and Aging

Functional outcomes in head and neck cancer

Evaluations of quality of life and organ function

RETRACTED ARTICLE: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension

Modeling Long-Term Cost-Effectiveness of Sitagliptin and SGLT2i Combination Therapy for the Treatment of Type 2 Diabetes

Cost Effectiveness of DPP-4i and SGLT2i Combination Therapy for the Treatment of Type 2 Diabetes in the U.S

Suchergebnisse filtern